[
  {
    "data": {
      "text": "Takarada et al., A Comparison of the antibacterial efficacies of essential oilsagainst oral bacteria (2004)6. Chih P. C., Toshiaki D., Preparation of alginate complex capsules containingeucalyptus essential oil and its controlled release, Colloids and surfaces (2003)7. N. Bou-Chacra et al., Antimicrobial activity of four different dental gel formulason cariogenic bacteria evaluated using the linear regression method (2005)FORMULATsIJA NA DENTALEN GEL SOMIKROChESTIChKI SO ENKAPSULIRANOETERIChNO MASLO OD ChAJNO DRVO,MELALEUCA ALTERNIFOLIAM. Stefkova, M. Glavash Dodov, N. Geshkovski, M. Simonoska Tsrtsarevska, K. GorachinovaFarmatsevtski fakultet, Vodnjanska 17, 1000 Skopje, RepublikaMakedonijaVOVEDGingivitisot pretstavuva nedestruktivna periodentalna bolestkoja e najchesto predizvikana od bakteriski biofilm, tkn. plaka,adkheriran na povrshinata na zabnoto tkivo i e najchesta forma naperiodentalno zaboluvanje (1). Potentsijalot za lokalno deluvanjei prodolzhuvanje na vremeto na zadrzhuvanje na sistemot, kako ikontroliranjeto na brzinata na osloboduvanje na aktivnatasupstantsija, pretstavuvaat ratsionalen pristap kon formuliranjena efikasna i stabilna terapevtska dozirana forma za tretmanna periodentalnite zaboluvanja (2). Dentalnite gelovi kakofarmatsevtski dozirani formi obezbeduvaat prolongiranokontaktno vreme i mozhnost za pretsizno doziranje na aktivnatasupstantsa lokalno, na mestoto na infektsijata. Alginatot, so svoite muko/bioatkhezivni karakteristiki, bi okom -pa ti bilnost i biorazgradivost i efekti na pH zavisno babrenjenudi mozhnost za prodolzheno osloboduvanje na aktivni molekuli ie odlichen kandidat za dizajniranje na mikropartikularni sistemiso kontrolirano osloboduvanje. Eterichnoto maslo od chajno drvo,Melaleuca alternifolia, Myrtaceae, ima silno antimikrobno dejstvoosobeno vrz kariogenite bakterii (3, 4, 5).Ottuka, tsel na ovoj trud beshe razvoj na formulatsija na dentalengel so inkorporirani kaltsium-alginatni mikrochestichki (MPs), vokoi beshe enkapsulirano eterichno maslo od chajno drvo. MATERIJALI I METODIPodgotovka na formulatsiite. Za podgotovka na MPs bea koristeninatrium alginat (Protanal LF 10/60, FMC BioPolymer, Norway),kaltsium khlorid (Alkaloid, Makedonija) i eterichno maslo od chajnodrvo (Melaleuca aetheroleum, Jan Spider, Hrvatska). Postapkata sesostoeshe od emugiranje na eterichnoto maslo od chajno drvo i negovoenkapsuliranje vo kaltsium alginatni (Ca-Alg) MPs, so primena naednostepena postapka na rasprsnuvanje bez sushenje (Buchi MiniSpray dryer B-290, Switzerland) (6). Dobienata vodena disperzija naMPs (VD Ca-Alg Mps) ponatamu beshe liofilizirana (LF Ca-Alg MPs)(Labconco, FreeZone 2.5L Freeze Dry System, USA). 305Macedonian Pharmaceutical Bulletin 57 (suppl), 2011PHARMACEUTICAL TECHNOLOGY AND BIOPHARMACYposter presentationsFIFTH CONGRESS OF PHARMACY OF MACEDONIA WITH INTERNATIONAL PARTICIPATIONZa podgotovka na dentalniot gel koristen beshe Noveon AA-1(Noveon Europe BVBA, Belgium), polimer na akrilna kiselina,vkrsteno povrzan so divinil glikol. Liofiliziranite chestichki(LF Ca-Alg MPs) bea inkorporirani vo pretkhodno podgotveniot gelvo kontsentratsija od 2% (m/m).Karakterizatsija na podgotvenite formulatsii. Srednata goleminai distributsijata na chestichkite po golemina beshe opredelena soprimena na laserska difraktometrija (Mastersizer 2000, MalvernInstr., Ltd, UK). So istata tekhnika opredelen e stepenot na babrenjena Ca-Alg MPs vo simulirana plunka (so pH 7.4), vo intervali od 1,3, 5 i 24 chasa.Za protsenka na antimikrobnata aktivnost na podgotvenite Ca-AlgMPs koristen e metod na difuzija na agar (7). Koristena e bakterijaStreptococcus mutans, ATCC 25175, kako najchest predizvikuvach nagingivitis (1).Stabilnosta na podgotvenite gel formulatsii so inkorporiraniCa-Alg MPs beshe ispituvana vo tek na 6 mesetsi, chuvani na 25 oC +- 2oC / 65% RH +- 5% RH i 37 oC +- 2 oC / 65% RH +- 5% RH, preku sledenjena parametri izgled i pH na gelot.REZULTATI I DISKUSIJA So primena na tekhnika na emulgiranje i rasprsnuvanje bez sushenjepodgotveni bea VD Ca-Alg Mps i LF Ca-Alg MPs so enkapsuliranomaslo od chajno drvo i opredelena e nivnata golemina. Srednatagolemina na chestichkite od podgotvenite formulatsii e dadena voTabela 1.Tabela 1. Sreden volumenski dijametar na podgotveniteformulatsii (n=6)Evaluatsijata na rezultatite od izvrshenite merenja na stepenot naba brenje na Ca-Alg MPs so inkorporirano eterichno maslo od chajnodrvo vo simulirana plunka so pH 7.4 (Slika 1) vo razlichni vre men -ski intervali vo tek na 24 chasa, ukazha na nivno izrazeno babrenjeshto e vo prilog na prodolzhenoto zadrzhuvanje na gingivite ipotentsijal za postepeno osloboduvanje na aktivnata supstantsija. Slika 1. Stepen na babrenje na podgotvenite formulatsii vosimulirana plunka so pH 7.4Pri protsenkata na antimikrobnata aktivnost na podgotvenite Ca-Alg MPs so metod na difuzija na agar dobieni bea zoni nainkhibitsija na rast na ispituvanata bakterija koi soodvetstvuvaatso literaturnite podatotsi za MIC (Minimum Inhibitory Concentra-tion, % v/v) na eterichnoto maslo od chajno drvo (0.25 - 2.0 % v/v) (4,5). Podgotvenite gel formulatsii pokazhaa zadovolitelna stabilnostvo ispituvaniot period.ZAKLUChOKPodgotvenata formulatsija na dentalen gel so inkorporiranimikrochestichki so eterichno maslo, dobieni so modifitsiranametoda na rasprsnuvanje so sushenje, pokazhuvaat potentsijal zaobezbeduvanjena lokalno antibakterisko deluvanje i efikasnostvo terapijata na periodentalnite zaboluvanja.LITERATURA1. Tanzer JM, Livingston J, Thompson AK, The microbiology of primary dental caries inhumans, J Dent Educ., 65, 1028-1037 (2001)2. Bruschi et al., Oral bioadhesive drug delivery systems, Drug Development andIndustrial Pharmacy, 31, 293-310 (2005)3. Finlay et al., Antiinflamatory activity of tea tree oil (2003)4. Riley , The antimicrobial activity of tea tree oil (2003)5. Takarada et al., A Comparison of the antibacterial efficacies of essential oils againstoral bacteria (2004)6. Chih P. C., Toshiaki D., Preparation of alginate complex capsules containingeucalyptus essential oil and its controlled release, Colloids and surfaces (2003)7. N. Bou-Chacra et al., Antimicrobial activity of four different dental gel formulas oncariogenic bacteria evaluated using the linear regression method (2005)STRATEGIES FOR IMPROVMENTOF THE EPR EFFECT OF PLGA AMPHIPILIC NANOPARTICLESM. S. Crcarevska1, N. Geskovski1, M. G. Dodov1, S. Calis2, S. Dimcevska1, K. Goracinova1 1Faculty of Pharmacy, University of Ss Cyril and Methodius, Vodnjanska17, 1000 Skopje, Macedonia 2Faculty of Pharmacy, Haccetepe University, 06100Ankara, TurkeyINTORDUCTIONNanoparticle (NP) delivery of anticancer drugs to tumour tissues canbe achieved by either passive or active targeting. Passive targetingtakes the advantage of the inherent size of NP and exploits the uniqueanatomical and pathophysiological abnormalities of tumourvasculature, such as the enhanced permeability and retention (EPR)effect. The EPR effect seems to bridge the advances in na notechno -logy and the advances in the understanding of tumour vascular biologyand, hence, is regarded as a 'gold standard' in the design of newanticancer agents. This approach can effectively enhance drugbioavailability and efficacy [1]. For extravasation of the drug-loadedcarrier more selectively at tumour tissues, at least some properties ofnanocarriers are particularly important. To successfully take advan ta -ge of NP for drug delivery, a number of significant parameters,including size, size distribution, drug loading capacity and inc o rpo ra -tion of functionalities, have to be carefully considered and optimizedin each application. We developed modified nanoprecipitation method for hydrophilic drugloading into PLGA amphiphilic nanocarriers [2, 3]. The particles havebeen made of Poly(D,L-lactide-co-glycolide) (PLGA) and tri-block306Makedonski farmatsevtski bilten 57 (dodatok), 2011FARMATsEVTSKA TEKhNOLOGIJA I BIOFARMATsIJAposter prezentatsiiPETTI KONGRES NA FARMATsIJATA SO MEGjUNARODNO UChESTVOcopolymer Pluronic(r) F127 (F127). F127 was used in the formulation inorder to turn the hydrophobic PLGA surface into a hydrophilic one. Asmodel drug for water soluble substance irinotecan hydrochloride (IR-HCl) was used.MATERIALS AND METHODSPLGA (lactate/glycolate ratio 85/15) was purchased from Sigma,Germany, while F127 was generous gift from BASF, Germany. IR-HClwas obtained from Bio-tech Co., China. All other chemicals were ofanalytical grade.PREPARATION AND CHARACTERIZATION OF NANOPARTICLESNP were prepared by modified nanoprecipitation method [2, 3]. Threeformulations with different proportion of polymers and same drugquantity, produced under identical operating conditions, wereprepared. Composition of prepared formulations is given in Table 1.Table 1. Composition of nanoparticles loaded with IR-HClNP were characterized in terms of morphology (Jeol-SEM 6400, Japan),particle size, polydispersity index (PDI) and zeta potential (ZetasizerNano Series, Nano-ZS, Malvern Instruments Ltd., UK). Encapsulationefficiency (EE) was determined by validated HPLC method, afterseparation by size-exclusion chromatography (Sephadex G-25 column)and/ or centrifugal ultrafiltration (Vivaspin 20, 1000 KDa, SartoriusStedim Biotech GmbH, Germany). Drug release studies were con-ducted under sink conditions in PBS, during 5 days. F127 quantity in-corporated in the nanoparticles was determined. Hence, adsorptionstudies were conducted and amount of F127 bound to the surface ofprepared NP was ascertained using standard depletion method [4].RESULTS AND DISCUSSIONNP prepared by modified nanoprecipitation, robust and reproducible,production process were with acceptable spherical morphology andsmooth surface. Particle size, PDI and encapsulation efficiency arepresented in Table 2. The particle size of prepared formulations was inrequired size range of 20-200 nm, which results in unique interactionwith biological systems at the molecular level, thus favoring capital-ization on EPR effect for passive accumulation in the target tumortissues. Having in mind that formulations were prepared under iden-tical operating conditions, it is most likely that initial quantity of F127used in the formulation has impact on particle size, i.e. higherconcentration lead to a reduced NP size. Low values for zeta potentialof prepared NP (-1 to -5 mV) are in favor of desired lower opsonizationrate thus indicating their ability to be hidden from the RES and henceto prolong blood circulation time.Table 2. Z-average, PDI and EE of NP (mean +- SD, n = 6)As it can be seen from Fig.1 the amount of drug released during theperiod of initial release was probably affected by the composition ofthe nanoparticles, thus increasing when the F127 content in the NPwas increased. Drug release pattern best fits to Korsmeyer-Peppasmodel indicating that diffusion is main controlling mechanism for drugrelease.Having in mind that opsonization and removal of drug carrier systemfrom the body by RES, is major obstacle for EPR effect, the surface ofNP must be sterically stabilized in order to be present in the bloodlong enough to reach its therapeutic site of action. This could beachieved by incorporation and further adsorption of F127 onto thesurface of NP. F127 quantity in prepared NP and consequently ad-sorbed amount, determined using depletion method, are presentedin Table 3. Higher initial F127 quantity used in the production of NP re-sulted with more hydrophilic NP surface. Fig 1. In vitro release profile of IR-HCl from prepared NP in PBS pH 7.4at 37 +- 0.5 degC (mean +- SD, n = 3)Table 3. Quantity of incorporated and adsorbed F127 in preparednanoparticles expressed as mg F127/mg PLGA +- SDCONCLUSIONThe current study has shown that prepared PLGA amphiphilic NP (i)exhibit adequate size and surface charge; (ii) efficient drug loading; (iii)controlled release properties and (iv) have sterically stabilized, hy-drophilic surface. It could be concluded that prepared NP can be usedas promising carriers for solid tumor targeting utilizing EPR effect, butfurther optimization is necessary to exploit their full potential. Ourfuture work will focus on the suitability and application of these car-riers in vivo on animal models.REFERENCES1. Maeda, H. (2001). The enhanced permeability and retention (EPR) effect in tumorvasculature: the key role of tumor-selective macromolecular drug targeting, AdvEnzyme Regul 41: 189-207.2. Glavas, M., Calis, S., Simonoska M., Geskovski, N., Goracinova, K. (2011). Colloidalcarriers for anticancer drug delivery - formulation aspects, Proceedings ofInternational Symposium on Drug Research and Development, Antalya, Turkey 3. Simonoska Crcarevska, M., Geskovski, N., Kuzmanovska, S., Glavas Dodov, M.,Calis, S., Goracinova, K. (2011). Preparation and biological evaluation of irinotecanloaded biodegradable nanocarriers for tumour delivery by EPR effect, Proceedingsof 3rd PharmSciFair, Prague, Czech Republic4. Shar, J. A., Obey, T. M., Cosgrove, T. (1998). Adsorption studies of polyethers Part1. Adsorption onto hydrophobic surfaces.Colloid Surface A 136 (1-2): 21-33.307Macedonian Pharmaceutical Bulletin 57 (suppl), 2011PHARMACEUTICAL TECHNOLOGY AND BIOPHARMACYposter presentationsFIFTH CONGRESS OF PHARMACY OF MACEDONIA WITH INTERNATIONAL PARTICIPATIONSTRATEGIJA ZA OBEZBEDUVANjE NA EPREFEKT NA PLGA AMFIFILNINANOChESTIChKIM."
    },
    "predictions": [
      {
        "result": [
          {
            "id": "entity_0",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 1745,
              "end": 1767,
              "text": "Melaleuca alternifolia",
              "labels": [
                "Scientific Plant Name"
              ]
            }
          },
          {
            "id": "entity_1",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 3635,
              "end": 3641,
              "text": "mutans",
              "labels": [
                "Scientific Fungus Name"
              ]
            }
          },
          {
            "id": "entity_2",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 5808,
              "end": 5821,
              "text": "antimicrobial",
              "labels": [
                "Medicinal Effect"
              ]
            }
          },
          {
            "from_id": "entity_0",
            "to_id": "entity_2",
            "type": "relation",
            "labels": [
              "has_medicinal_effect"
            ]
          },
          {
            "from_id": "entity_2",
            "to_id": "entity_1",
            "type": "relation",
            "labels": [
              "treats_medical_condition"
            ]
          }
        ]
      }
    ]
  }
]